BioCentury | Nov 17, 2017
Financial News

Xeltis raises EUR45M series C

...Capital and existing investors LSP, Kurma Partners and VI Partners. Other undisclosed investors also participated. Xeltis...
...The European and Asian Xplore-I feasibility trial is also evaluating the valve. Xeltis AG, Zurich, Switzerland Jennie Walters Xeltis AG...
BioCentury | Dec 21, 2015
Financial News

Xeltis financial update

...Xeltis AG , Zurich, Switzerland Business: Cardiovascular Date announced: 2015-12-17 Note: Xeltis raised EUR3 million ($3.3...
...million ($36.7 million). Lifecare Partners and an undisclosed new private investor participated in the extension. Xeltis...
BioCentury | Dec 8, 2014
Financial News

Xeltis completes venture financing

Xeltis AG , Zurich, Switzerland Business: Cardiovascular Date completed: 2014-12-02 Type: Venture financing Raised: €27 million ($33.4 million) Investors: LSP-Life Sciences Partners; Kurma Partners; VI Partners; existing investors WIR Staff...
BioCentury | Dec 4, 2014
Financial News

Xeltis raises EUR 27M in series B

...Regenerative medicine play Xeltis AG (Zurich, Switzerland) raised EUR 27 million ($33.6 million) in a series B...
...New investor VI Partners and undisclosed existing investors, including family offices and angels, also participated. Xeltis...
...blood vessel matrices designed to stimulate natural tissue growth. CEO Laurent Grandidier told BioCentury that Xeltis...
BioCentury | Oct 31, 2011
Company News

Xeltis AG management update

Xeltis AG , Zurich, Switzerland Business: Transplant Hired: Laurent Grandidier as CEO, formerly VP of sales and marketing at Endosense S.A. ; he replaces Thomas Sulzer, who will remain a director WIR Staff...
Items per page:
1 - 5 of 5
BioCentury | Nov 17, 2017
Financial News

Xeltis raises EUR45M series C

...Capital and existing investors LSP, Kurma Partners and VI Partners. Other undisclosed investors also participated. Xeltis...
...The European and Asian Xplore-I feasibility trial is also evaluating the valve. Xeltis AG, Zurich, Switzerland Jennie Walters Xeltis AG...
BioCentury | Dec 21, 2015
Financial News

Xeltis financial update

...Xeltis AG , Zurich, Switzerland Business: Cardiovascular Date announced: 2015-12-17 Note: Xeltis raised EUR3 million ($3.3...
...million ($36.7 million). Lifecare Partners and an undisclosed new private investor participated in the extension. Xeltis...
BioCentury | Dec 8, 2014
Financial News

Xeltis completes venture financing

Xeltis AG , Zurich, Switzerland Business: Cardiovascular Date completed: 2014-12-02 Type: Venture financing Raised: €27 million ($33.4 million) Investors: LSP-Life Sciences Partners; Kurma Partners; VI Partners; existing investors WIR Staff...
BioCentury | Dec 4, 2014
Financial News

Xeltis raises EUR 27M in series B

...Regenerative medicine play Xeltis AG (Zurich, Switzerland) raised EUR 27 million ($33.6 million) in a series B...
...New investor VI Partners and undisclosed existing investors, including family offices and angels, also participated. Xeltis...
...blood vessel matrices designed to stimulate natural tissue growth. CEO Laurent Grandidier told BioCentury that Xeltis...
BioCentury | Oct 31, 2011
Company News

Xeltis AG management update

Xeltis AG , Zurich, Switzerland Business: Transplant Hired: Laurent Grandidier as CEO, formerly VP of sales and marketing at Endosense S.A. ; he replaces Thomas Sulzer, who will remain a director WIR Staff...
Items per page:
1 - 5 of 5